Experiments for taxon Physalis philadelphica (SOLANACEAE)

71 experiments

Experiment	Worktypes	Pharmacology	Organism (specimen)	Compound
279997	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis philadelphica (SOLANACEAE)	OCTADECANE-1-3(S)-4(R)-TRIOL,2(S)-TETRACOSANOYL-AMINO:
279979	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL TRANSFORMATION INHIBITION	Physalis philadelphica (SOLANACEAE)	IXOCARPALACTONE B
279986	UV SPECTRUM GIVEN FORQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Physalis philadelphica (SOLANACEAE)	WITHANOLIDE D,18-HYDROXY:
296994	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINONE REDUCTASE INDUCTION	Physalis philadelphica (SOLANACEAE)	IXOCARPALACTONE A,2-3-DIHYDRO: 3-BETA-METHOXY:
279975	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINONE REDUCTASE INDUCTION	Physalis philadelphica (SOLANACEAE)	PHILADELPHICALACTONE B
297002	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINONE REDUCTASE INDUCTION	Physalis philadelphica (SOLANACEAE)	IXOCARPALACTONE A
645709	MEDICINAL FOLKLORE REPORTED FOR	ANTITOXIC ACTIVITY	Physalis philadelphica (SOLANACEAE)
210270	MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Physalis philadelphica (SOLANACEAE)	WITHANOLIDE D,24-25-DIHYDRO:
279981	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINONE REDUCTASE INDUCTION	Physalis philadelphica (SOLANACEAE)	IXOCARPALACTONE A
296998	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINONE REDUCTASE INDUCTION	Physalis philadelphica (SOLANACEAE)	IXOCARPALACTONE B,2-3-DIHYDRO:
279992	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINONE REDUCTASE INDUCTION	Physalis philadelphica (SOLANACEAE)	OCTADEC-TRANS-9-ENE,1-3(S)-4(R)-TRIHYDROXY-2-[2'(R)-HYDROXY-TETRACOSANOYL-AMINO]:
297001	MASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATACD SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Physalis philadelphica (SOLANACEAE)	IXOCARPALACTONE A
828074	MEDICINAL FOLKLORE REPORTED FOR	CONDIMENT	Physalis philadelphica (SOLANACEAE)
279970	VOUCHER SPECIMEN REPORTED FOR		Physalis philadelphica (SOLANACEAE)
210269	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL PROLIFERATION INHIBITION	Physalis philadelphica (SOLANACEAE)	WITHAPHYSACARPIN
279991	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis philadelphica (SOLANACEAE)	OCTADEC-TRANS-9-ENE,1-3(S)-4(R)-TRIHYDROXY-2-[2'(R)-HYDROXY-TETRACOSANOYL-AMINO]:
645710	MEDICINAL FOLKLORE REPORTED FOR	ANTILEPROTIC ACTIVITY	Physalis philadelphica (SOLANACEAE)
279980	UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Physalis philadelphica (SOLANACEAE)	IXOCARPALACTONE A
645715	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Physalis philadelphica (SOLANACEAE)
297003	VOUCHER SPECIMEN REPORTED FORIDENTIFICATION IN BY GC/MS		Physalis philadelphica (SOLANACEAE)	IXOCARPALACTONE B,2-3-DIHYDRO: 3-BETA-METHOXY:IXOCARPALACTONE AIXOCARPALACTONE A,2-3-DIHYDRO: 3-BETA-METHOXY:
210262	PHARMACOLOGY OF EXTRACT - IN VITRO	QUINONE REDUCTASE INDUCTION	Physalis philadelphica (SOLANACEAE)
279998	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Physalis philadelphica (SOLANACEAE)	CHLOROPHYLLIDE ALPHA
210263	PHARMACOLOGY OF EXTRACT - IN VITRO	QUINONE REDUCTASE INDUCTION	Physalis philadelphica (SOLANACEAE)
210266	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL PROLIFERATION INHIBITION	Physalis philadelphica (SOLANACEAE)	WITHAPHYSACARPIN,2-3-DIHYDRO: 3-METHOXY:
494269	ANTICANCER AND/OR CYTOTOXICITY MARKER CODEMEDICINAL FOLKLORE REPORTED FOR	ANTIBACTERIAL ACTIVITY	Physalis philadelphica (SOLANACEAE)
645708	MEDICINAL FOLKLORE REPORTED FOR	BLOOD SYSTEM EFFECTS(UNSPECIFIED)	Physalis philadelphica (SOLANACEAE)
279987	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINONE REDUCTASE INDUCTION	Physalis philadelphica (SOLANACEAE)	WITHANOLIDE D,18-HYDROXY:
279973	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL TRANSFORMATION INHIBITION	Physalis philadelphica (SOLANACEAE)	PHILADELPHICALACTONE A
210259	VOUCHER SPECIMEN REPORTED FOR		Physalis philadelphica (SOLANACEAE)
279995	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINONE REDUCTASE INDUCTION	Physalis philadelphica (SOLANACEAE)	OCTADECANE-1-3(S)-4-(R)-TRIOL,2(S)-[2'(R)-HYDROXY-TETRACOSANOYL-AMINO]:
297000	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINONE REDUCTASE INDUCTION	Physalis philadelphica (SOLANACEAE)	WITHA-2-5-DIEN-22-26-OLIDE,4-BETA-7-BETA-20(R)-TRIHYDROXY-1-OXO:
279976	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL TRANSFORMATION INHIBITION	Physalis philadelphica (SOLANACEAE)	PHILADELPHICALACTONE B
279984	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINONE REDUCTASE INDUCTION	Physalis philadelphica (SOLANACEAE)	WITHAPHYSACARPIN
296997	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR		Physalis philadelphica (SOLANACEAE)	IXOCARPALACTONE B,2-3-DIHYDRO:
296999	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis philadelphica (SOLANACEAE)	WITHA-2-5-DIEN-22-26-OLIDE,4-BETA-7-BETA-20(R)-TRIHYDROXY-1-OXO:
279990	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINONE REDUCTASE INDUCTION	Physalis philadelphica (SOLANACEAE)	WITHANONE
279988	PHARMACOLOGY OF COMPOUND - IN VITRO	FUNGAL STIMULANT	Physalis philadelphica (SOLANACEAE)	WITHANOLIDE D,18-HYDROXY:
280000	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL TRANSFORMATION INHIBITION	Physalis philadelphica (SOLANACEAE)	CHLOROPHYLLIDE ALPHA
210272	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL PROLIFERATION INHIBITION	Physalis philadelphica (SOLANACEAE)	WITHANOLIDE D,24-25-DIHYDRO:
645714	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Physalis philadelphica (SOLANACEAE)
279999	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINONE REDUCTASE INDUCTION	Physalis philadelphica (SOLANACEAE)	CHLOROPHYLLIDE ALPHA
645711	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Physalis philadelphica (SOLANACEAE)
210261	PHARMACOLOGY OF EXTRACT - IN VITRO	QUINONE REDUCTASE INDUCTION	Physalis philadelphica (SOLANACEAE)
296996	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINONE REDUCTASE INDUCTION	Physalis philadelphica (SOLANACEAE)	IXOCARPALACTONE B,2-3-DIHYDRO: 3-BETA-METHOXY:
279972	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINONE REDUCTASE INDUCTION	Physalis philadelphica (SOLANACEAE)	PHILADELPHICALACTONE A
296993	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR		Physalis philadelphica (SOLANACEAE)	IXOCARPALACTONE A,2-3-DIHYDRO: 3-BETA-METHOXY:
210265	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINONE REDUCTASE INDUCTION	Physalis philadelphica (SOLANACEAE)	WITHAPHYSACARPIN,2-3-DIHYDRO: 3-METHOXY:
279977	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis philadelphica (SOLANACEAE)	IXOCARPALACTONE B
645707	VOUCHER SPECIMEN REPORTED FOR		Physalis philadelphica (SOLANACEAE)
279994	PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis philadelphica (SOLANACEAE)	OCTADECANE-1-3(S)-4-(R)-TRIOL,2(S)-[2'(R)-HYDROXY-TETRACOSANOYL-AMINO]:
279983	UV SPECTRUM GIVEN FORQUANTITATIVE DATAINFRARED SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF		Physalis philadelphica (SOLANACEAE)	WITHAPHYSACARPIN
140988	ISOLATION AND IDENTIFICATION OF		Physalis philadelphica (SOLANACEAE)	PHYGRINE
210267	PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Physalis philadelphica (SOLANACEAE)	WITHAPHYSACARPIN
210271	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINONE REDUCTASE INDUCTION	Physalis philadelphica (SOLANACEAE)	WITHANOLIDE D,24-25-DIHYDRO:
210260	MEDICINAL FOLKLORE REPORTED FOR	FOOD USE	Physalis philadelphica (SOLANACEAE)
279996	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL TRANSFORMATION INHIBITION	Physalis philadelphica (SOLANACEAE)	OCTADECANE-1-3(S)-4-(R)-TRIOL,2(S)-[2'(R)-HYDROXY-TETRACOSANOYL-AMINO]:
279985	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL TRANSFORMATION INHIBITION	Physalis philadelphica (SOLANACEAE)	WITHAPHYSACARPIN
279974	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis philadelphica (SOLANACEAE)	PHILADELPHICALACTONE B
976192	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIYEAST ACTIVITY	Physalis philadelphica (SOLANACEAE)
645712	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Physalis philadelphica (SOLANACEAE)
279989	UV SPECTRUM GIVEN FORQUANTITATIVE DATAISOLATION AND IDENTIFICATION OF		Physalis philadelphica (SOLANACEAE)	WITHANONE
279978	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINONE REDUCTASE INDUCTION	Physalis philadelphica (SOLANACEAE)	IXOCARPALACTONE B
976191	VOUCHER SPECIMEN REPORTED FOR		Physalis philadelphica (SOLANACEAE)
296995	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR		Physalis philadelphica (SOLANACEAE)	IXOCARPALACTONE B,2-3-DIHYDRO: 3-BETA-METHOXY:
210268	PHARMACOLOGY OF COMPOUND - IN VITRO	QUINONE REDUCTASE INDUCTION	Physalis philadelphica (SOLANACEAE)	WITHAPHYSACARPIN
645713	PHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	ANTIBACTERIAL ACTIVITY	Physalis philadelphica (SOLANACEAE)
296992	VOUCHER SPECIMEN REPORTED FOR		Physalis philadelphica (SOLANACEAE)
279982	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL TRANSFORMATION INHIBITION	Physalis philadelphica (SOLANACEAE)	IXOCARPALACTONE A
279971	UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis philadelphica (SOLANACEAE)	PHILADELPHICALACTONE A
279993	PHARMACOLOGY OF COMPOUND - IN VITRO	CELL TRANSFORMATION INHIBITION	Physalis philadelphica (SOLANACEAE)	OCTADEC-TRANS-9-ENE,1-3(S)-4(R)-TRIHYDROXY-2-[2'(R)-HYDROXY-TETRACOSANOYL-AMINO]:
210264	UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR		Physalis philadelphica (SOLANACEAE)	WITHAPHYSACARPIN,2-3-DIHYDRO: 3-METHOXY:

Experiments for taxon Physalis philadelphica (SOLANACEAE)

Experiments (71 results)

Filters

Worktypes (17)

Pharmacology (12)

Compounds (19)

Organisms (9)